Advancing Treatment Paradigms in Glaucoma: The Impact and Innovation of PAXTRAVA in Redefining Intraocular Pressure Management

Scheduled for:May 30, 2024 8:00 PM EDT

Call Duration:30 minutes

Desired Expert

An ophthalmologist or glaucoma specialist with extensive experience in the diagnosis and management of glaucoma. The expert should possess a deep understanding of intraocular pressure (IOP) control mechanisms and familiarity with innovative therapeutic approaches. Proficiency in interpreting clinical trial data and assessing treatment efficacy and safety is essential.

Interview Goal

This interview aims to explore the transformative effects of PAXTRAVA™ (travoprost intracameral implant or OTX-TIC) on the management of open-angle glaucoma or ocular hypertension. Focusing on the positive Phase 2 data presented at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting, we seek to discuss the significant findings, safety profile, and potential implications for future treatment strategies. Additionally, we aim to assess the broader impact of PAXTRAVA™ on patient care and the evolving landscape of glaucoma management.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.